Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 130
- Locations
- 1
- Primary Endpoint
- Current Opioid misuse measure (COMM) surveys
Study Overview
Brief Summary
Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •With diagnoses related to chronic lower back pain
- •Age above 18yrs
- •Non pregnant
Exclusion Criteria
- •Cancer pain
Outcomes
Primary Outcomes
Current Opioid misuse measure (COMM) surveys
Time Frame: within 12 months
Current opioid misuse measures with the Current Opioid misuse measure (COMM) surveys. The COMM is a 17-item self-report measure with total scores ranging from 0 to 68 that is used to identify risk of opioid misuse among chronic pain patients, with higher scores indicating higher risk of opioid misuse.
Screener and Opioid Assessment for patients with pain revised (SOAPPR)
Time Frame: within 12 months
Risk of opioid misuse with the Screener and Opioid Assessment for Patients with Pain Revised (SOAPPR). The Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R) is a 24-item self-report questionnaire with total scores ranging from 0 to 24 that is used to predict risk of aberrant medication-related behaviors among chronic pain patients, with higher scores indicating higher risk of aberrant behaviors.
Secondary Outcomes
- Pain Intensity with Brief Pain inventory (BPI)(within 12 months)
Investigators
Chinwe Nwaneshiudu
Assistant Professor
Icahn School of Medicine at Mount Sinai